Atlas Trials

Recurrent Primary Peritoneal Cavity Cancer

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Primary Peritoneal Cavity Cancer

RecordFirmDate
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02122185)University of Chicago2015-02-25
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT02046421)University of Chicago2013-11-01
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01962948)Fox Chase Cancer Center2013-10-09
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT01747798)Mayo Clinic2012-11-02
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT01536054)Roswell Park Cancer Institute2012-08-20
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (NCT01652794)Case Comprehensive Cancer Center2012-05-01
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (NCT01764789)Ohio State University Comprehensive Cancer Center2010-10-01
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin (NCT01200797)National Cancer Institute (NCI)2010-07-01
Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00388037)National Cancer Institute (NCI)2007-01-01
AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery (NCT00348699)National Cancer Institute (NCI)2006-07-01
Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer (NCT00278343)National Cancer Institute (NCI)2006-04-01
Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer (NCT00096395)National Cancer Institute (NCI)2004-09-01
Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00083122)National Cancer Institute (NCI)2004-04-01
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02050009)Fox Chase Cancer Center

Track Recurrent Primary Peritoneal Cavity Cancer automatically

Every clearance here is in the API, with alerts when new ones post.